Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-01-12
1995-10-10
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142352, 514300, 514312, 544127, 544128, 546113, 546123, 546156, 252403, A61K 3147, A61K 31435, C07D47104, C07D21556
Patent
active
054571049
ABSTRACT:
The invention relates to new quinolone- and naphthyridonecarboxylic acid derivatives which have hydrogen in the 6-position, to processes for their preparation, and to antibacterial compositions and feed additives containing them.
REFERENCES:
patent: 4416884 (1983-11-01), Ishikawa et al.
patent: 4544747 (1985-10-01), Ishikawa et al.
patent: 4762844 (1988-08-01), Grohe et al.
patent: 4804760 (1989-02-01), Schriewer et al.
patent: 4870182 (1989-09-01), Schriewer et al.
patent: 5270340 (1993-12-01), Kunisch et al.
Journal of Medicinal Chemistry, 35, pp. 198-200 (1992).
J. Am. Chem. Soc. 100, pp. 5179-5185 (1978).
J. Org. Chem. 43, pp. 2164-2167 (1978).
J. Org. Chem. 40, pp. 24-28 (1975).
Houben-Weyl, Methoden der Org. Chemie, Bd. E4, pp. 144-149 (1983).
JFW McOmie, Protective Groups In Org. Chemistry (1973), p. 43.
P. A. Grieco et al., Tetrahedreon 42, pp. 2847-2853 (1986).
JP 1,308,281 (Abstract) (1990).
Helvetica Chimica Acta 59, pp. 222-229 (1976).
JP 3,291,258 (Abstract) (1991).
Japanese Abstract 1,308,281, Dain, Pharmaceuticals, p. 14, Week 9004 (1990).
Bartel Stephan
Bremm Klaus-Dieter
Endermann Rainer
Grohe Klaus
Krebs Andreas
Bayer Aktiengesellschaft
Dentz Bernard
LandOfFree
Quinolone- and naphthyridonecarboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinolone- and naphthyridonecarboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinolone- and naphthyridonecarboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2310538